Focal Pulsed Field Ablation of Ventricular Tachycardia
Key facts
- Where
- Wismar, GermanySee the site
Where in Germany
- Sana HANSE Hospital WismarWismar, GermanyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sana Hanse Hospital Wismar
- Trial code
- NCT07929545
- Record updated
- 10 November 2026
- Original description
The PULSE-VT Registry is a combined retrospective and prospective, multi-centre, observational registry designed to evaluate the safety and efficacy of focal pulsed-field ablation (fPFA) using the Centauri™ generator for catheter ablation of ventricular tachycardia (VT). The registry captures detailed procedural, clinical, and follow-up data across participating electrophysiology centres performing VT ablation with this ablation energy modality.Read full original descriptionShow less
Multicenter Study on Effectiveness and Safety of Focal Pulsed Field Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease
The PULSE-VT Registry is a combined retrospective and prospective, multi-centre, observational registry designed to evaluate the safety and efficacy of focal pulsed-field ablation (fPFA) using the Centauri™ generator for catheter ablation of ventricular tachycardia (VT). The registry captures detailed procedural, clinical, and follow-up data across participating electrophysiology centres performing VT ablation with this ablation energy modality.
Inclusion: Age ≥ 18 years at the time of the ablation procedure; Documented ventricular tachycardia (sustained or non-sustained) requiring catheter ablation; Clinical indication for VT ablation including one or more of the following:; Recurrent sustained VT; Electrical storm (≥ 3 separate VT episodes within 24 hours); Recurrent ICD shock or anti-tachycardia pacing (ATP) therapy; Recurrent non-sustained VT causing symptoms or haemodynamic compromise; Procedure performed using focal pulsed-field ablation (fPFA) with the Centauri™ generator (as primary or adjunctive ablation energy); Written informed consent obtained.
Exclusion: Life expectancy < 12 months due to non-cardiac comorbidity; Age < 18 years; Refusal to provide consent for data collection; Ablation procedure performed without use of the Centauri™ PFA generator; Pregnancy at the time of the procedure.